parallel randomized trial
SURMOUNT-OSA
A Master Protocol to Investigate the Efficacy and Safety of Tirzepatide Once Weekly in Participants Who Have Obstructive Sleep Apnea and Obesity: A Randomized, Double-Blind, Placebo-Controlled Trial
Design
Conduct and analysis
Arms
| Arm | Treatment | Background | Randomized | Analyzed | Completed treatment |
|---|---|---|---|---|---|
| A1 | Tirzepatide subcutaneous once weekly, maximum tolerated dose: 10 or 15 mg Tirzepatide MTD, trial 1 (no PAP) | no PAP therapy; lifestyle: standard | 114 | 114 | 97 |
| A2 | Placebo Placebo, trial 1 (no PAP) | no PAP therapy; lifestyle: standard | 120 | 120 | 84 |
| A3 | Tirzepatide subcutaneous once weekly, maximum tolerated dose: 10 or 15 mg Tirzepatide MTD, trial 2 (on PAP) | PAP therapy; lifestyle: standard | 120 | 119 | 108 |
| A4 | Placebo Placebo, trial 2 (on PAP) | PAP therapy; lifestyle: standard | 115 | 114 | 85 |
Baseline characteristics
As printed in the trial reports or registry, per arm or for the whole trial.
| Characteristic | Statistic | Tirzepatide subcutaneous once weekly, maximum tolerated dose: 10 or 15 mg A1 | Placebo A2 | Tirzepatide subcutaneous once weekly, maximum tolerated dose: 10 or 15 mg A3 | Placebo A4 |
|---|---|---|---|---|---|
| age: 50 or older | n | 51 | 58 | 66 | 70 |
| age: 50 or older | percent | 44.7 | 48.3 | 55.0 | 60.9 |
| age: less than 50 | n | 63 | 62 | 54 | 45 |
| age: less than 50 | percent | 55.3 | 51.7 | 45.0 | 39.1 |
| age | mean (years) | 47.3 | 48.4 | 50.8 | 52.7 |
| age | sd (years) | 11.0 | 11.9 | 10.7 | 11.3 |
| ahi: 15 to less than 30 | n | 39 | 43 | 35 | 37 |
| ahi: 15 to less than 30 | percent | 34.2 | 36.1 | 29.4 | 32.5 |
| ahi: 30 or more | n | 74 | 73 | 84 | 75 |
| ahi: 30 or more | percent | 64.9 | 61.3 | 70.6 | 65.8 |
| ahi: less than 15 | n | 1 | 2 | 0 | 2 |
| ahi: less than 15 | percent | 0.9 | 1.7 | 1.8 | |
| ahi: no apnea | n | 0 | 1 | ||
| ahi: no apnea | percent | 0.8 | |||
| ahi | mean (events per hour) | 52.9 | 50.1 | 46.1 | 53.1 |
| ahi | sd (events per hour) | 30.5 | 31.5 | 22.4 | 30.2 |
| asian | n | 23 | 24 | 17 | 16 |
| asian | percent | 20.2 | 20.0 | 14.2 | 14.0 |
| black | n | 6 | 7 | 8 | 3 |
| black | percent | 5.3 | 5.8 | 6.7 | 2.6 |
| bmi: 35 to less than 40 | n | 39 | 35 | 47 | 41 |
| bmi: 35 to less than 40 | percent | 34.2 | 29.2 | 39.5 | 36.0 |
| bmi: 40 or more | n | 42 | 41 | 39 | 40 |
| bmi: 40 or more | percent | 36.8 | 34.2 | 32.8 | 35.1 |
| bmi: less than 35 | n | 33 | 44 | 33 | 33 |
| bmi: less than 35 | percent | 28.9 | 36.7 | 27.7 | 28.9 |
| bmi | mean (kg/m2) | 39.7 | 38.6 | 38.6 | 38.7 |
| bmi | sd (kg/m2) | 7.3 | 6.7 | 6.1 | 6.0 |
| female | n | 36 | 41 | 33 | 32 |
| female | percent | 31.6 | 34.2 | 27.5 | 27.8 |
| hba1c | mean (percent) | 5.69 | 5.64 | 5.62 | 5.65 |
| hba1c | sd (percent) | 0.37 | 0.35 | 0.37 | 0.44 |
| hispanic | n | 51 | 47 | 38 | 38 |
| hispanic | percent | 44.7 | 39.2 | 31.7 | 33.0 |
| other race american indian alaska native | n | 9 | 9 | 10 | 9 |
| other race american indian alaska native | percent | 7.9 | 7.5 | 8.3 | 7.9 |
| other race multiple | n | 2 | 0 | 0 | 0 |
| other race multiple | percent | 1.8 | |||
| other race native hawaiian pacific islander | n | 0 | 0 | 0 | 0 |
| sbp | mean (mmHg) | 128.4 | 130.3 | 130.5 | 130.5 |
| sbp | sd (mmHg) | 12.2 | 10.7 | 14.3 | 12.8 |
| waist | mean (cm) | 122.6 | 119.8 | 120.7 | 121.0 |
| waist | sd (cm) | 16.6 | 14.8 | 13.1 | 14.0 |
| weight | mean (kg) | 116.7 | 112.8 | 115.8 | 115.1 |
| weight | sd (kg) | 24.6 | 22.6 | 21.5 | 22.7 |
| white | n | 74 | 80 | 85 | 86 |
| white | percent | 64.9 | 66.7 | 70.8 | 75.4 |
Results
299 adjudicated result lines, grouped by outcome. Open an outcome to see its values.
Systolic blood pressure change (18 lines; O05)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 48 | A1 | change | -9.6 mmHg | 1.1 | hypothetical; modified itt; R0016217:Table 2 | ||
| 48 | A1 | change | -9.5 mmHg | -11.5 to -7.5 | 114 | treatment policy; modified itt; R0018977:Table 2 | |
| 48 | A1 vs A2 | md | -7.6 mmHg | -10.5 to -4.8 | treatment policy; modified itt; R0018977:Table 2 | ||
| 48 | A1 vs A2 | md | -7.9 mmHg | -11.0 to -4.9 | hypothetical; modified itt; R0016217:Table 2 | ||
| 48 | A2 | change | -1.8 mmHg | -3.9 to 0.2 | 120 | treatment policy; modified itt; R0018977:Table 2 | |
| 48 | A2 | change | -1.7 mmHg | 1.1 | hypothetical; modified itt; R0016217:Table 2 | ||
| 48 | A3 | change | -7.6 mmHg | 1.1 | hypothetical; modified itt; R0016217:Table 2 | ||
| 48 | A3 | change | -7.6 mmHg | -9.7 to -5.6 | 120 | treatment policy; modified itt; R0018977:Table 2 | |
| 48 | A3 vs A4 | md | -4.3 mmHg | -7.3 to -1.2 | hypothetical; modified itt; R0016217:Table 2 | ||
| 48 | A3 vs A4 | md | -3.7 mmHg | -6.8 to -0.7 | treatment policy; modified itt; R0018977:Table 2 | ||
| 48 | A4 | change | -3.9 mmHg | -6.3 to -1.6 | 115 | treatment policy; modified itt; R0018977:Table 2 | |
| 48 | A4 | change | -3.3 mmHg | 1.2 | hypothetical; modified itt; R0016217:Table 2 | ||
| 52 | A1 vs A2 | md | -6.8 mmHg | -9.6 to -4.0 | hypothetical; modified itt; R0005976:Supplement Table S2 | ||
| 52 | A1 | change | -9.7 mmHg | 0.97 | hypothetical; modified itt; R0005976:Supplement Table S2 | ||
| 52 | A2 | change | -2.9 mmHg | 1.04 | hypothetical; modified itt; R0005976:Supplement Table S2 | ||
| 52 | A3 | change | -8.7 mmHg | 1.01 | hypothetical; modified itt; R0005976:Supplement Table S2 | ||
| 52 | A3 vs A4 | md | -7.2 mmHg | -10.2 to -4.2 | hypothetical; modified itt; R0005976:Supplement Table S2 | ||
| 52 | A4 | change | -1.6 mmHg | 1.13 | hypothetical; modified itt; R0005976:Supplement Table S2 |
Percent body weight change (102 lines; O10)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 20 | A1 | percent change | -11.00 percent | 0.44 | hypothetical; modified itt; R0011011:Table 2 | ||
| 20 | A1 vs A2 | md | -8.8 percent | -10.1 to -7.6 | hypothetical; modified itt; R0011011:Results | ||
| 20 | A2 | percent change | -2.20 percent | 0.45 | hypothetical; modified itt; R0011011:Table 2 | ||
| 20 | A3 | percent change | -12.60 percent | 0.44 | hypothetical; modified itt; R0011011:Table 2 | ||
| 20 | A3 vs A4 | md | -10.0 percent | -11.3 to -8.8 | hypothetical; modified itt; R0011011:Results | ||
| 20 | A4 | percent change | -2.60 percent | 0.46 | hypothetical; modified itt; R0011011:Table 2 | ||
| 24 | A1 | percent change | -12.80 percent | 0.49 | hypothetical; modified itt; R0011011:Table 2 | ||
| 24 | A2 | percent change | -2.30 percent | 0.50 | hypothetical; modified itt; R0011011:Table 2 | ||
| 24 | A3 | percent change | -14.50 percent | 0.49 | hypothetical; modified itt; R0011011:Table 2 | ||
| 24 | A4 | percent change | -2.30 percent | 0.52 | hypothetical; modified itt; R0011011:Table 2 | ||
| 36 | A1 | percent change | -15.90 percent | 0.59 | hypothetical; modified itt; R0011011:Table 2 | ||
| 36 | A2 | percent change | -2.20 percent | 0.61 | hypothetical; modified itt; R0011011:Table 2 | ||
| 36 | A3 | percent change | -17.80 percent | 0.64 | hypothetical; modified itt; R0011011:Table 2 | ||
| 36 | A4 | percent change | -2.50 percent | 0.68 | hypothetical; modified itt; R0011011:Table 2 | ||
| 48 | A1 | percent change | -17.60 percent | 0.68 | hypothetical; modified itt; R0011011:Table 2 | ||
| 48 | A2 | percent change | -1.90 percent | 0.71 | hypothetical; modified itt; R0011011:Table 2 | ||
| 48 | A3 | percent change | -19.40 percent | 0.72 | hypothetical; modified itt; R0011011:Table 2 | ||
| 48 | A4 | percent change | -2.30 percent | 0.77 | hypothetical; modified itt; R0011011:Table 2 | ||
| 52 | A1 | percent change | -17.2 percent | 1.02 | hypothetical; modified itt; bmi:30_to_less_than_35; R0005976:Supplement Table S14 | ||
| 52 | A1 | percent change | -16.3 percent | 1.39 | hypothetical; modified itt; sex:female; R0005976:Supplement Table S10 | ||
| 52 | A1 vs A2 | md | -14.6 percent | -18.5 to -10.7 | hypothetical; modified itt; sex:female; R0005976:Supplement Table S10 | ||
| 52 | A1 | percent change | -19.0 percent | 0.80 | hypothetical; modified itt; sex:male; R0005976:Supplement Table S10 | ||
| 52 | A1 vs A2 | md | -17.7 percent | -20.1 to -15.4 | hypothetical; modified itt; sex:male; R0005976:Supplement Table S10 | ||
| 52 | A1 | percent change | -18.10 percent | 0.71 | hypothetical; modified itt; R0011011:Table 2 | ||
| 52 | A1 vs A2 | md | -16.8 percent | -18.8 to -14.7 | hypothetical; modified itt; R0011011:Results | ||
| 52 | A1 | percent change | -17.7 percent | -19.0 to -16.3 | 114 | treatment policy; modified itt; R0018977:Table 2 | |
| 52 | A1 vs A2 | md | -16.1 percent | -18.0 to -14.2 | treatment policy; modified itt; R0018977:Table 2 | ||
| 52 | A1 | percent change | -18.8 percent | 1.04 | hypothetical; modified itt; age:50_or_older; R0005976:Supplement Table S8 | ||
| 52 | A1 vs A2 | md | -16.8 percent | -19.6 to -13.9 | hypothetical; modified itt; age:50_or_older; R0005976:Supplement Table S8 | ||
| 52 | A1 | percent change | -18.7 percent | 7 | hypothetical; modified itt; age:65_or_older; R0013402:Figure 1 | ||
| 52 | A1 vs A2 | md | -17.1 percent | -23.3 to -10.9 | hypothetical; modified itt; age:65_or_older; R0013402:Figure 1 | ||
| 52 | A1 | percent change | -17.6 percent | 0.97 | hypothetical; modified itt; age:less_than_50; R0005976:Supplement Table S8 | ||
| 52 | A1 vs A2 | md | -16.8 percent | -19.7 to -13.9 | hypothetical; modified itt; age:less_than_50; R0005976:Supplement Table S8 | ||
| 52 | A1 | percent change | -18.2 percent | 105 | hypothetical; modified itt; age:less_than_65; R0013402:Figure 1 | ||
| 52 | A1 vs A2 | md | -16.9 percent | -19.0 to -14.8 | hypothetical; modified itt; age:less_than_65; R0013402:Figure 1 | ||
| 52 | A1 | percent change | -18.4 percent | 1.26 | hypothetical; modified itt; ahi:15_to_less_than_30; R0005976:Supplement Table S12 | ||
| 52 | A1 vs A2 | md | -16.1 percent | -19.7 to -12.5 | hypothetical; modified itt; ahi:15_to_less_than_30; R0005976:Supplement Table S12 | ||
| 52 | A1 | percent change | -18.9 percent | 1.07 | hypothetical; modified itt; ahi:30_to_less_than_70; R0005976:Supplement Table S12 | ||
| 52 | A1 vs A2 | md | -19.8 percent | -22.9 to -16.7 | hypothetical; modified itt; ahi:30_to_less_than_70; R0005976:Supplement Table S12 | ||
| 52 | A1 | percent change | -16.9 percent | 1.34 | hypothetical; modified itt; ahi:70_or_more; R0005976:Supplement Table S12 | ||
| 52 | A1 vs A2 | md | -13.6 percent | -17.6 to -9.6 | hypothetical; modified itt; ahi:70_or_more; R0005976:Supplement Table S12 | ||
| 52 | A1 vs A2 | md | -16.0 percent | -20.3 to -11.7 | hypothetical; modified itt; bmi:40_or_more; R0005976:Supplement Table S14 | ||
| 52 | A1 vs A2 | md | -16.5 percent | -19.3 to -13.6 | hypothetical; modified itt; bmi:30_to_less_than_35; R0005976:Supplement Table S14 | ||
| 52 | A1 | percent change | -20.2 percent | 0.96 | hypothetical; modified itt; bmi:35_to_less_than_40; R0005976:Supplement Table S14 | ||
| 52 | A1 vs A2 | md | -17.8 percent | -20.7 to -15.0 | hypothetical; modified itt; bmi:35_to_less_than_40; R0005976:Supplement Table S14 | ||
| 52 | A1 | percent change | -17.0 percent | 1.46 | hypothetical; modified itt; bmi:40_or_more; R0005976:Supplement Table S14 | ||
| 52 | A2 | percent change | -2.4 percent | 1.03 | hypothetical; modified itt; bmi:35_to_less_than_40; R0005976:Supplement Table S14 | ||
| 52 | A2 | percent change | -3.3 percent | 1.46 | hypothetical; modified itt; ahi:70_or_more; R0005976:Supplement Table S12 | ||
| 52 | A2 | percent change | -2.0 percent | 0.99 | hypothetical; modified itt; age:50_or_older; R0005976:Supplement Table S8 | ||
| 52 | A2 | percent change | -0.7 percent | 1.01 | hypothetical; modified itt; bmi:30_to_less_than_35; R0005976:Supplement Table S14 | ||
| 52 | A2 | percent change | -1.6 percent | 1.37 | hypothetical; modified itt; sex:female; R0005976:Supplement Table S10 | ||
| 52 | A2 | percent change | -1.30 percent | 0.73 | hypothetical; modified itt; R0011011:Table 2 | ||
| 52 | A2 | percent change | -2.3 percent | 1.26 | hypothetical; modified itt; ahi:15_to_less_than_30; R0005976:Supplement Table S12 | ||
| 52 | A2 | percent change | -1.2 percent | 0.85 | hypothetical; modified itt; sex:male; R0005976:Supplement Table S10 | ||
| 52 | A2 | percent change | -1.6 percent | 12 | hypothetical; modified itt; age:65_or_older; R0013402:Figure 1 | ||
| 52 | A2 | percent change | -1.6 percent | -2.9 to -0.2 | 120 | treatment policy; modified itt; R0018977:Table 2 | |
| 52 | A2 | percent change | -1.0 percent | 1.58 | hypothetical; modified itt; bmi:40_or_more; R0005976:Supplement Table S14 | ||
| 52 | A2 | percent change | 0.9 percent | 1.12 | hypothetical; modified itt; ahi:30_to_less_than_70; R0005976:Supplement Table S12 | ||
| 52 | A2 | percent change | -1.3 percent | 103 | hypothetical; modified itt; age:less_than_65; R0013402:Figure 1 | ||
| 52 | A2 | percent change | -0.7 percent | 1.09 | hypothetical; modified itt; age:less_than_50; R0005976:Supplement Table S8 | ||
| 52 | A3 vs A4 | md | -16.3 percent | -19.5 to -13.2 | hypothetical; modified itt; ahi:30_to_less_than_70; R0005976:Supplement Table S13 | ||
| 52 | A3 vs A4 | md | -17.8 percent | -19.9 to -15.7 | hypothetical; modified itt; R0011011:Results | ||
| 52 | A3 vs A4 | md | -18.6 percent | -23.0 to -14.2 | hypothetical; modified itt; bmi:40_or_more; R0005976:Supplement Table S15 | ||
| 52 | A3 | percent change | -19.6 percent | -21.0 to -18.2 | 120 | treatment policy; modified itt; R0018977:Table 2 | |
| 52 | A3 vs A4 | md | -17.3 percent | -19.3 to -15.3 | treatment policy; modified itt; R0018977:Table 2 | ||
| 52 | A3 | percent change | -20.10 percent | 0.73 | hypothetical; modified itt; R0011011:Table 2 | ||
| 52 | A3 | percent change | -19.9 percent | 0.98 | hypothetical; modified itt; age:50_or_older; R0005976:Supplement Table S9 | ||
| 52 | A3 vs A4 | md | -16.8 percent | -19.6 to -14.0 | hypothetical; modified itt; age:50_or_older; R0005976:Supplement Table S9 | ||
| 52 | A3 | percent change | -19.6 percent | 1.88 | hypothetical; modified itt; ahi:70_or_more; R0005976:Supplement Table S13 | ||
| 52 | A3 vs A4 | md | -16.9 percent | -21.7 to -12.2 | hypothetical; modified itt; ahi:70_or_more; R0005976:Supplement Table S13 | ||
| 52 | A3 | percent change | -20.6 percent | 12 | hypothetical; modified itt; age:65_or_older; R0013402:Figure 1 | ||
| 52 | A3 vs A4 | md | -15.2 percent | -19.7 to -10.8 | hypothetical; modified itt; age:65_or_older; R0013402:Figure 1 | ||
| 52 | A3 vs A4 | md | -16.4 percent | -18.9 to -13.8 | hypothetical; modified itt; sex:male; R0005976:Supplement Table S11 | ||
| 52 | A3 | percent change | -18.9 percent | 0.87 | hypothetical; modified itt; sex:male; R0005976:Supplement Table S11 | ||
| 52 | A3 | percent change | -20.5 percent | 1.08 | hypothetical; modified itt; bmi:35_to_less_than_40; R0005976:Supplement Table S15 | ||
| 52 | A3 | percent change | -20.3 percent | 1.11 | hypothetical; modified itt; age:less_than_50; R0005976:Supplement Table S9 | ||
| 52 | A3 vs A4 | md | -19.0 percent | -22.3 to -15.6 | hypothetical; modified itt; age:less_than_50; R0005976:Supplement Table S9 | ||
| 52 | A3 vs A4 | md | -21.4 percent | -25.0 to -17.9 | hypothetical; modified itt; sex:female; R0005976:Supplement Table S11 | ||
| 52 | A3 vs A4 | md | -17.3 percent | -20.5 to -14.1 | hypothetical; modified itt; bmi:35_to_less_than_40; R0005976:Supplement Table S15 | ||
| 52 | A3 | percent change | -20.0 percent | 106 | hypothetical; modified itt; age:less_than_65; R0013402:Figure 1 | ||
| 52 | A3 vs A4 | md | -18.2 percent | -20.6 to -15.9 | hypothetical; modified itt; age:less_than_65; R0013402:Figure 1 | ||
| 52 | A3 | percent change | -23.1 percent | 1.23 | hypothetical; modified itt; sex:female; R0005976:Supplement Table S11 | ||
| 52 | A3 | percent change | -19.0 percent | 1.22 | hypothetical; modified itt; bmi:30_to_less_than_35; R0005976:Supplement Table S15 | ||
| 52 | A3 vs A4 | md | -17.9 percent | -21.4 to -14.4 | hypothetical; modified itt; bmi:30_to_less_than_35; R0005976:Supplement Table S15 | ||
| 52 | A3 | percent change | -21.8 percent | 1.35 | hypothetical; modified itt; ahi:15_to_less_than_30; R0005976:Supplement Table S13 | ||
| 52 | A3 vs A4 | md | -20.3 percent | -24.2 to -16.5 | hypothetical; modified itt; ahi:15_to_less_than_30; R0005976:Supplement Table S13 | ||
| 52 | A3 | percent change | -20.8 percent | 1.51 | hypothetical; modified itt; bmi:40_or_more; R0005976:Supplement Table S15 | ||
| 52 | A3 | percent change | -19.2 percent | 0.95 | hypothetical; modified itt; ahi:30_to_less_than_70; R0005976:Supplement Table S13 | ||
| 52 | A4 | percent change | -2.7 percent | 1.46 | hypothetical; modified itt; ahi:70_or_more; R0005976:Supplement Table S13 | ||
| 52 | A4 | percent change | -2.30 percent | 0.78 | hypothetical; modified itt; R0011011:Table 2 | ||
| 52 | A4 | percent change | -2.3 percent | -3.8 to -0.9 | 115 | treatment policy; modified itt; R0018977:Table 2 | |
| 52 | A4 | percent change | -3.1 percent | 1.00 | hypothetical; modified itt; age:50_or_older; R0005976:Supplement Table S9 | ||
| 52 | A4 | percent change | -5.4 percent | 19 | hypothetical; modified itt; age:65_or_older; R0013402:Figure 1 | ||
| 52 | A4 | percent change | -1.3 percent | 1.28 | hypothetical; modified itt; age:less_than_50; R0005976:Supplement Table S9 | ||
| 52 | A4 | percent change | -1.8 percent | 94 | hypothetical; modified itt; age:less_than_65; R0013402:Figure 1 | ||
| 52 | A4 | percent change | -1.5 percent | 1.39 | hypothetical; modified itt; ahi:15_to_less_than_30; R0005976:Supplement Table S13 | ||
| 52 | A4 | percent change | -2.9 percent | 1.26 | hypothetical; modified itt; ahi:30_to_less_than_70; R0005976:Supplement Table S13 | ||
| 52 | A4 | percent change | -1.1 percent | 1.25 | hypothetical; modified itt; bmi:30_to_less_than_35; R0005976:Supplement Table S15 | ||
| 52 | A4 | percent change | -3.2 percent | 1.21 | hypothetical; modified itt; bmi:35_to_less_than_40; R0005976:Supplement Table S15 | ||
| 52 | A4 | percent change | -2.2 percent | 1.61 | hypothetical; modified itt; bmi:40_or_more; R0005976:Supplement Table S15 | ||
| 52 | A4 | percent change | -1.7 percent | 1.29 | hypothetical; modified itt; sex:female; R0005976:Supplement Table S11 | ||
| 52 | A4 | percent change | -2.5 percent | 0.95 | hypothetical; modified itt; sex:male; R0005976:Supplement Table S11 |
Acute kidney injury (4 lines; O121)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 114 | not stated; safety; registry:adverse_events | ||||
| A2 | events | 0 / 120 | not stated; safety; registry:adverse_events | ||||
| A3 | events | 1 / 119 | not stated; safety; registry:adverse_events | ||||
| A4 | events | 0 / 114 | not stated; safety; registry:adverse_events |
All cause mortality (4 lines; O20)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 114 | not stated; safety; R0018977:Table 4 | ||||
| A2 | events | 0 / 120 | not stated; safety; R0018977:Table 4 | ||||
| A3 | events | 0 / 119 | not stated; safety; R0018977:Table 4 | ||||
| A4 | events | 0 / 114 | not stated; safety; R0018977:Table 4 |
Three point MACE (3 lines; O21)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 114 | not stated; safety; R0018977:Table 4 | ||||
| A2 | events | 0 / 120 | not stated; safety; R0018977:Table 4 | ||||
| A3 | events | 0 / 119 | not stated; safety; R0018977:Table 4 |
Four point MACE including unstable angina (7 lines; O21B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 114 | not stated; safety; R0018977:Table 4 | ||||
| A1 | events | 0 / 114 | not stated; safety; R0018977:Table 4 | ||||
| A2 | events | 0 / 120 | not stated; safety; R0018977:Table 4 | ||||
| A2 | events | 0 / 120 | not stated; safety; R0018977:Table 4 | ||||
| A3 | events | 0 / 119 | not stated; safety; R0018977:Table 4 | ||||
| A3 | events | 0 / 119 | not stated; safety; R0018977:Table 4 | ||||
| A4 | events | 1 / 114 | not stated; safety; R0018977:Table 4 |
Hospitalization for heart failure (3 lines; O23)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 114 | not stated; safety; R0018977:Table 4 | ||||
| A2 | events | 0 / 120 | not stated; safety; R0018977:Table 4 | ||||
| A3 | events | 0 / 119 | not stated; safety; R0018977:Table 4 |
SF-36 physical component summary change (1 lines; O24A)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 20 | A1 vs A2 | md | 2.2 points | 0.5 to 3.9 | treatment policy; modified itt; R0016265:Results |
Physical functioning (any instrument) (1 lines; O24B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 20 | A1 vs A2 | md | 2.1 points | 0.5 to 3.7 | treatment policy; modified itt; R0016265:Results |
Health related quality of life total score (any instrument) (2 lines; O24C)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 52 | A1 vs A2 | md | 0.04 points | 0.00 to 0.08 | treatment policy; modified itt; R0016265:Results | ||
| 52 | A3 vs A4 | md | 0.05 points | 0.01 to 0.09 | treatment policy; modified itt; R0016265:Results |
Serious adverse events (4 lines; O25)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 9 / 114 | not stated; safety; R0018977:Table 4 | ||||
| A2 | events | 7 / 120 | not stated; safety; R0018977:Table 4 | ||||
| A3 | events | 7 / 119 | not stated; safety; R0018977:Table 4 | ||||
| A4 | events | 12 / 114 | not stated; safety; R0018977:Table 4 |
Discontinuation due to adverse events (8 lines; O26)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 5 / 114 | not stated; safety; R0018977:Table 4 | ||||
| A1 | events | 0 / 114 | not stated; randomized; R0018977:Supplement Figure S3 | ||||
| A2 | events | 2 / 120 | not stated; randomized; R0018977:Supplement Figure S3 | ||||
| A2 | events | 2 / 120 | not stated; safety; R0018977:Table 4 | ||||
| A3 | events | 1 / 120 | not stated; randomized; R0018977:Supplement Figure S3 | ||||
| A3 | events | 4 / 119 | not stated; safety; R0018977:Table 4 | ||||
| A4 | events | 5 / 115 | not stated; randomized; R0018977:Supplement Figure S3 | ||||
| A4 | events | 8 / 114 | not stated; safety; R0018977:Table 4 |
Nausea (4 lines; O27A)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 29 / 114 | not stated; safety; R0018977:Table 4 | ||||
| A2 | events | 12 / 120 | not stated; safety; R0018977:Table 4 | ||||
| A3 | events | 26 / 119 | not stated; safety; R0018977:Table 4 | ||||
| A4 | events | 6 / 114 | not stated; safety; R0018977:Table 4 |
Vomiting (4 lines; O27B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 20 / 114 | not stated; safety; R0018977:Table 4 | ||||
| A2 | events | 5 / 120 | not stated; safety; R0018977:Table 4 | ||||
| A3 | events | 11 / 119 | not stated; safety; R0018977:Table 4 | ||||
| A4 | events | 1 / 114 | not stated; safety; R0018977:Table 4 |
Diarrhea (8 lines; O27C)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 30 / 114 | not stated; safety; R0018977:Table 4 | ||||
| A1 | events | 1 / 114 | not stated; safety; registry:adverse_events | ||||
| A2 | events | 15 / 120 | not stated; safety; R0018977:Table 4 | ||||
| A2 | events | 0 / 120 | not stated; safety; registry:adverse_events | ||||
| A3 | events | 26 / 119 | not stated; safety; R0018977:Table 4 | ||||
| A3 | events | 1 / 119 | not stated; safety; registry:adverse_events | ||||
| A4 | events | 10 / 114 | not stated; safety; R0018977:Table 4 | ||||
| A4 | events | 0 / 114 | not stated; safety; registry:adverse_events |
Constipation (4 lines; O27D)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 18 / 114 | not stated; safety; R0018977:Table 4 | ||||
| A2 | events | 3 / 120 | not stated; safety; R0018977:Table 4 | ||||
| A3 | events | 18 / 119 | not stated; safety; R0018977:Table 4 | ||||
| A4 | events | 5 / 114 | not stated; safety; R0018977:Table 4 |
Gallbladder and biliary disease (16 lines; O28)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 114 | not stated; safety; cholelithiasis; registry:adverse_events | ||||
| A1 | events | 0 / 114 | not stated; safety; cholelithiasis; registry:adverse_events | ||||
| A1 | events | 1 / 114 | not stated; safety; gallbladder polyp; registry:adverse_events | ||||
| A1 | events | 0 / 114 | not stated; safety; gallbladder polyp; registry:adverse_events | ||||
| A2 | events | 1 / 120 | not stated; safety; gallbladder polyp; registry:adverse_events | ||||
| A2 | events | 0 / 120 | not stated; safety; gallbladder polyp; registry:adverse_events | ||||
| A2 | events | 1 / 120 | not stated; safety; cholelithiasis; registry:adverse_events | ||||
| A2 | events | 0 / 120 | not stated; safety; cholelithiasis; registry:adverse_events | ||||
| A3 | events | 0 / 119 | not stated; safety; gallbladder polyp; registry:adverse_events | ||||
| A3 | events | 0 / 119 | not stated; safety; cholelithiasis; registry:adverse_events | ||||
| A3 | events | 2 / 119 | not stated; safety; cholelithiasis; registry:adverse_events | ||||
| A3 | events | 0 / 119 | not stated; safety; gallbladder polyp; registry:adverse_events | ||||
| A4 | events | 0 / 114 | not stated; safety; gallbladder polyp; registry:adverse_events | ||||
| A4 | events | 0 / 114 | not stated; safety; gallbladder polyp; registry:adverse_events | ||||
| A4 | events | 0 / 114 | not stated; safety; cholelithiasis; registry:adverse_events | ||||
| A4 | events | 1 / 114 | not stated; safety; cholelithiasis; registry:adverse_events |
Acute pancreatitis (12 lines; O29)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 114 | not stated; safety; R0018977:Table 4 | ||||
| A1 | events | 0 / 114 | not stated; safety; registry:adverse_events | ||||
| A1 | events | 0 / 114 | not stated; safety; registry:adverse_events | ||||
| A2 | events | 0 / 120 | not stated; safety; registry:adverse_events | ||||
| A2 | events | 0 / 120 | not stated; safety; R0018977:Table 4 | ||||
| A2 | events | 0 / 120 | not stated; safety; registry:adverse_events | ||||
| A3 | events | 2 / 119 | not stated; safety; R0018977:Table 4 | ||||
| A3 | events | 1 / 119 | not stated; safety; registry:adverse_events | ||||
| A3 | events | 1 / 119 | not stated; safety; registry:adverse_events | ||||
| A4 | events | 0 / 114 | not stated; safety; R0018977:Table 4 | ||||
| A4 | events | 0 / 114 | not stated; safety; registry:adverse_events | ||||
| A4 | events | 0 / 114 | not stated; safety; registry:adverse_events |
Medullary thyroid carcinoma (4 lines; O32A)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 114 | not stated; safety; R0018977:Table 4 | ||||
| A2 | events | 0 / 120 | not stated; safety; R0018977:Table 4 | ||||
| A3 | events | 0 / 119 | not stated; safety; R0018977:Table 4 | ||||
| A4 | events | 0 / 114 | not stated; safety; R0018977:Table 4 |
Thyroid cancer (any) (4 lines; O32B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 114 | not stated; safety; R0018977:Table 4 | ||||
| A2 | events | 0 / 120 | not stated; safety; R0018977:Table 4 | ||||
| A3 | events | 0 / 119 | not stated; safety; R0018977:Table 4 | ||||
| A4 | events | 0 / 114 | not stated; safety; R0018977:Table 4 |
Suicidal ideation or behavior (4 lines; O35A)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 2 / 114 | not stated; safety; suicide attempt; registry:adverse_events | ||||
| A2 | events | 0 / 120 | not stated; safety; suicide attempt; registry:adverse_events | ||||
| A3 | events | 0 / 119 | not stated; safety; suicide attempt; registry:adverse_events | ||||
| A4 | events | 0 / 114 | not stated; safety; suicide attempt; registry:adverse_events |
Death by suicide (4 lines; O35B)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| A1 | events | 0 / 114 | not stated; safety; R0018977:Table 4 | ||||
| A2 | events | 0 / 120 | not stated; safety; R0018977:Table 4 | ||||
| A3 | events | 0 / 119 | not stated; safety; R0018977:Table 4 | ||||
| A4 | events | 0 / 114 | not stated; safety; R0018977:Table 4 |
Apnea hypopnea index change (78 lines; O70)
| Week | Arm | Statistic | Estimate | SE or SD | 95% CI | Events / N | Detail |
|---|---|---|---|---|---|---|---|
| 52 | A1 | change | -27.4 events per hour | -31.6 to -23.2 | hypothetical; modified itt; R0018977:Results | ||
| 52 | A1 vs A2 | md | -22.5 events per hour | -28.7 to -16.4 | hypothetical; modified itt; R0018977:Results | ||
| 52 | A1 | change | -12.1 events per hour | 2.11 | hypothetical; modified itt; ahi:15_to_less_than_30; R0005976:Supplement Table S12 | ||
| 52 | A1 vs A2 | md | -23.9 events per hour | -31.6 to -16.3 | hypothetical; modified itt; sex:male; R0005976:Supplement Table S10 | ||
| 52 | A1 | change | -30.6 events per hour | 2.59 | hypothetical; modified itt; sex:male; R0005976:Supplement Table S10 | ||
| 52 | A1 vs A2 | md | -18.8 events per hour | -29.9 to -7.6 | hypothetical; modified itt; sex:female; R0005976:Supplement Table S10 | ||
| 52 | A1 | change | -25.3 events per hour | -29.3 to -21.2 | 114 | treatment policy; modified itt; R0018977:Table 2 | |
| 52 | A1 | percent change | -50.7 percent | -62.3 to -39.1 | 114 | treatment policy; modified itt; R0018977:Table 2 | |
| 52 | A1 vs A2 | md | -20.0 events per hour | -25.8 to -14.2 | treatment policy; modified itt; R0018977:Table 2 | ||
| 52 | A1 vs A2 | md | -47.7 percent | -65.8 to -29.6 | treatment policy; modified itt; R0018977:Table 2 | ||
| 52 | A1 vs A2 | md | -11.3 events per hour | -17.4 to -5.2 | hypothetical; modified itt; ahi:15_to_less_than_30; R0005976:Supplement Table S12 | ||
| 52 | A1 | change | -28.3 events per hour | 3.88 | hypothetical; modified itt; ahi:30_to_less_than_70; R0005976:Supplement Table S12 | ||
| 52 | A1 | change | -19.8 events per hour | 3.86 | hypothetical; modified itt; sex:female; R0005976:Supplement Table S10 | ||
| 52 | A1 vs A2 | md | -26.4 events per hour | -39.3 to -13.5 | hypothetical; modified itt; bmi:40_or_more; R0005976:Supplement Table S14 | ||
| 52 | A1 | change | -27.9 events per hour | 4.31 | hypothetical; modified itt; bmi:40_or_more; R0005976:Supplement Table S14 | ||
| 52 | A1 vs A2 | md | -23.5 events per hour | -32.6 to -14.3 | hypothetical; modified itt; bmi:35_to_less_than_40; R0005976:Supplement Table S14 | ||
| 52 | A1 | change | -29.2 events per hour | 3.11 | hypothetical; modified itt; bmi:35_to_less_than_40; R0005976:Supplement Table S14 | ||
| 52 | A1 vs A2 | md | -19.0 events per hour | -29.2 to -8.8 | hypothetical; modified itt; bmi:30_to_less_than_35; R0005976:Supplement Table S14 | ||
| 52 | A1 | change | -27.8 events per hour | 3.08 | hypothetical; modified itt; age:50_or_older; R0005976:Supplement Table S8 | ||
| 52 | A1 vs A2 | md | -23.7 events per hour | -32.3 to -15.2 | hypothetical; modified itt; age:50_or_older; R0005976:Supplement Table S8 | ||
| 52 | A1 vs A2 | md | -30.5 events per hour | -41.8 to -19.3 | hypothetical; modified itt; ahi:30_to_less_than_70; R0005976:Supplement Table S12 | ||
| 52 | A1 | change | -25.2 events per hour | 3.49 | hypothetical; modified itt; bmi:30_to_less_than_35; R0005976:Supplement Table S14 | ||
| 52 | A1 vs A2 | md | -26.2 events per hour | -40.8 to -11.7 | hypothetical; modified itt; ahi:70_or_more; R0005976:Supplement Table S12 | ||
| 52 | A1 | change | -43.3 events per hour | 4.74 | hypothetical; modified itt; ahi:70_or_more; R0005976:Supplement Table S12 | ||
| 52 | A1 | change | -27.9 events per hour | 3.01 | hypothetical; modified itt; age:less_than_50; R0005976:Supplement Table S8 | ||
| 52 | A1 vs A2 | md | -22.9 events per hour | -32.2 to -13.7 | hypothetical; modified itt; age:less_than_50; R0005976:Supplement Table S8 | ||
| 52 | A2 | change | -4.8 events per hour | -9.3 to -0.3 | hypothetical; modified itt; R0018977:Results | ||
| 52 | A2 | change | -5.3 events per hour | -9.4 to -1.1 | 120 | treatment policy; modified itt; R0018977:Table 2 | |
| 52 | A2 | percent change | -3.0 percent | -16.9 to 10.9 | 120 | treatment policy; modified itt; R0018977:Table 2 | |
| 52 | A2 | change | -4.0 events per hour | 2.94 | hypothetical; modified itt; age:50_or_older; R0005976:Supplement Table S8 | ||
| 52 | A2 | change | -4.9 events per hour | 3.54 | hypothetical; modified itt; age:less_than_50; R0005976:Supplement Table S8 | ||
| 52 | A2 | change | -0.8 events per hour | 2.23 | hypothetical; modified itt; ahi:15_to_less_than_30; R0005976:Supplement Table S12 | ||
| 52 | A2 | change | 2.2 events per hour | 4.04 | hypothetical; modified itt; ahi:30_to_less_than_70; R0005976:Supplement Table S12 | ||
| 52 | A2 | change | -17.1 events per hour | 5.36 | hypothetical; modified itt; ahi:70_or_more; R0005976:Supplement Table S12 | ||
| 52 | A2 | change | -6.2 events per hour | 3.67 | hypothetical; modified itt; bmi:30_to_less_than_35; R0005976:Supplement Table S14 | ||
| 52 | A2 | change | -5.7 events per hour | 3.35 | hypothetical; modified itt; bmi:35_to_less_than_40; R0005976:Supplement Table S14 | ||
| 52 | A2 | change | -1.4 events per hour | 4.77 | hypothetical; modified itt; bmi:40_or_more; R0005976:Supplement Table S14 | ||
| 52 | A2 | change | -1.1 events per hour | 3.90 | hypothetical; modified itt; sex:female; R0005976:Supplement Table S10 | ||
| 52 | A2 | change | -6.6 events per hour | 2.85 | hypothetical; modified itt; sex:male; R0005976:Supplement Table S10 | ||
| 52 | A3 | change | -30.9 events per hour | 2.52 | hypothetical; modified itt; ahi:30_to_less_than_70; R0005976:Supplement Table S13 | ||
| 52 | A3 vs A4 | md | -22.5 events per hour | -30.9 to -14.1 | hypothetical; modified itt; ahi:30_to_less_than_70; R0005976:Supplement Table S13 | ||
| 52 | A3 vs A4 | md | -23.8 events per hour | -29.6 to -17.9 | treatment policy; modified itt; R0018977:Table 2 | ||
| 52 | A3 | percent change | -58.7 percent | -69.1 to -48.4 | 120 | treatment policy; modified itt; R0018977:Table 2 | |
| 52 | A3 | change | -32.6 events per hour | 2.48 | hypothetical; modified itt; sex:male; R0005976:Supplement Table S11 | ||
| 52 | A3 | change | -26.0 events per hour | 3.47 | hypothetical; modified itt; bmi:40_or_more; R0005976:Supplement Table S15 | ||
| 52 | A3 vs A4 | md | -21.8 events per hour | -32.4 to -11.2 | hypothetical; modified itt; bmi:40_or_more; R0005976:Supplement Table S15 | ||
| 52 | A3 | change | -29.3 events per hour | -33.2 to -25.4 | 120 | treatment policy; modified itt; R0018977:Table 2 | |
| 52 | A3 vs A4 | md | -25.1 events per hour | hypothetical; modified itt; sex:male; R0005976:Supplement Table S11 | |||
| 52 | A3 | change | -24.8 events per hour | 3.24 | hypothetical; modified itt; sex:female; R0005976:Supplement Table S11 | ||
| 52 | A3 vs A4 | md | -23.1 events per hour | -32.6 to -13.5 | hypothetical; modified itt; sex:female; R0005976:Supplement Table S11 | ||
| 52 | A3 | change | -12.6 events per hour | 2.84 | hypothetical; modified itt; ahi:15_to_less_than_30; R0005976:Supplement Table S13 | ||
| 52 | A3 vs A4 | md | -17.1 events per hour | -25.5 to -8.7 | hypothetical; modified itt; ahi:15_to_less_than_30; R0005976:Supplement Table S13 | ||
| 52 | A3 vs A4 | md | -28.6 events per hour | -38.6 to -18.5 | hypothetical; modified itt; age:less_than_50; R0005976:Supplement Table S9 | ||
| 52 | A3 | change | -34.1 events per hour | 3.14 | hypothetical; modified itt; age:less_than_50; R0005976:Supplement Table S9 | ||
| 52 | A3 vs A4 | md | -21.9 events per hour | -29.3 to -14.5 | hypothetical; modified itt; age:50_or_older; R0005976:Supplement Table S9 | ||
| 52 | A3 vs A4 | md | -24.4 events per hour | -30.3 to -18.6 | hypothetical; modified itt; R0018977:Results | ||
| 52 | A3 | change | -52.2 events per hour | 6.15 | hypothetical; modified itt; ahi:70_or_more; R0005976:Supplement Table S13 | ||
| 52 | A3 vs A4 | md | -34.0 events per hour | -50.1 to -17.8 | hypothetical; modified itt; ahi:70_or_more; R0005976:Supplement Table S13 | ||
| 52 | A3 | change | -27.7 events per hour | 2.58 | hypothetical; modified itt; age:50_or_older; R0005976:Supplement Table S9 | ||
| 52 | A3 | change | -30.4 events per hour | -34.3 to -26.5 | hypothetical; modified itt; R0018977:Results | ||
| 52 | A3 | change | -30.3 events per hour | 3.35 | hypothetical; modified itt; bmi:30_to_less_than_35; R0005976:Supplement Table S15 | ||
| 52 | A3 vs A4 | md | -23.0 events per hour | -32.9 to -13.0 | hypothetical; modified itt; bmi:30_to_less_than_35; R0005976:Supplement Table S15 | ||
| 52 | A3 vs A4 | md | -56.2 percent | -73.7 to -38.7 | treatment policy; modified itt; R0018977:Table 2 | ||
| 52 | A3 | change | -34.4 events per hour | 3.49 | hypothetical; modified itt; bmi:35_to_less_than_40; R0005976:Supplement Table S15 | ||
| 52 | A3 vs A4 | md | -27.8 events per hour | -38.5 to -17.1 | hypothetical; modified itt; bmi:35_to_less_than_40; R0005976:Supplement Table S15 | ||
| 52 | A4 | change | -8.4 events per hour | 3.38 | hypothetical; modified itt; ahi:30_to_less_than_70; R0005976:Supplement Table S13 | ||
| 52 | A4 | change | -5.8 events per hour | 2.68 | hypothetical; modified itt; age:50_or_older; R0005976:Supplement Table S9 | ||
| 52 | A4 | change | -5.5 events per hour | -9.9 to -1.2 | 115 | treatment policy; modified itt; R0018977:Table 2 | |
| 52 | A4 | change | -6.0 events per hour | -10.3 to -1.6 | hypothetical; modified itt; R0018977:Results | ||
| 52 | A4 | change | -7.5 events per hour | 2.78 | hypothetical; modified itt; sex:male; R0005976:Supplement Table S11 | ||
| 52 | A4 | change | -1.8 events per hour | 3.49 | hypothetical; modified itt; sex:female; R0005976:Supplement Table S11 | ||
| 52 | A4 | change | -18.2 events per hour | 5.09 | hypothetical; modified itt; ahi:70_or_more; R0005976:Supplement Table S13 | ||
| 52 | A4 | change | 4.5 events per hour | 3.07 | hypothetical; modified itt; ahi:15_to_less_than_30; R0005976:Supplement Table S13 | ||
| 52 | A4 | percent change | -2.5 percent | -16.2 to 11.2 | 115 | treatment policy; modified itt; R0018977:Table 2 | |
| 52 | A4 | change | -6.6 events per hour | 4.04 | hypothetical; modified itt; bmi:35_to_less_than_40; R0005976:Supplement Table S15 | ||
| 52 | A4 | change | -4.2 events per hour | 3.91 | hypothetical; modified itt; bmi:40_or_more; R0005976:Supplement Table S15 | ||
| 52 | A4 | change | -5.6 events per hour | 3.86 | hypothetical; modified itt; age:less_than_50; R0005976:Supplement Table S9 | ||
| 52 | A4 | change | -7.4 events per hour | 3.54 | hypothetical; modified itt; bmi:30_to_less_than_35; R0005976:Supplement Table S15 |